| Dr Terri L Dallas-prunskis, MD | |
|
4309 Medical Center Dr, B103, Mchenry, IL 60050 | |
| (815) 363-9595 | |
| (815) 578-4530 |
| Full Name | Dr Terri L Dallas-prunskis |
|---|---|
| Gender | Female |
| Speciality | Interventional Pain Management |
| Experience | 42 Years |
| Location | 4309 Medical Center Dr, Mchenry, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457375115 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 036073541 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwestern Medicine Mchenry Hospital | Mchenry, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Illinois Pain Treatment Institute Ltd | 3577464940 | 11 |
News Archive
A Judicial Review sought by the British Medical Association to challenge the government's decision to cap the pensions of GPs will take place in the High Court, London, on Wednesday and Thursday this week (12th and 13th March 2008).
ISENTRESS , an integrase inhibitor from Merck & Co., Inc., was studied in comparison to efavirenz in maintaining viral load suppression to undetectable levels (less than 50 copies/mL) and at improving CD4 cell counts in previously untreated (treatment-naïve) HIV-1-infected patients through 96 weeks in a Phase III study called STARTMRK.
Today's headlines include reports about the health portion of the President's budget blueprint along with the politics that accompany it.
Researchers from the ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) research consortium, have reported that a blood test could soon be an important diagnostic tool in detecting the abnormal proteins deposits in the brain that lead to the progressive and debilitating condition of Alzheimer's disease. The study titled, "Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration," was published in today's issue of the journal Nature Medicine.
› Verified 3 days ago
| Entity Name | Illinois Pain Treatment Institute Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295811479 PECOS PAC ID: 3577464940 Enrollment ID: O20040119000131 |
News Archive
A Judicial Review sought by the British Medical Association to challenge the government's decision to cap the pensions of GPs will take place in the High Court, London, on Wednesday and Thursday this week (12th and 13th March 2008).
ISENTRESS , an integrase inhibitor from Merck & Co., Inc., was studied in comparison to efavirenz in maintaining viral load suppression to undetectable levels (less than 50 copies/mL) and at improving CD4 cell counts in previously untreated (treatment-naïve) HIV-1-infected patients through 96 weeks in a Phase III study called STARTMRK.
Today's headlines include reports about the health portion of the President's budget blueprint along with the politics that accompany it.
Researchers from the ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) research consortium, have reported that a blood test could soon be an important diagnostic tool in detecting the abnormal proteins deposits in the brain that lead to the progressive and debilitating condition of Alzheimer's disease. The study titled, "Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration," was published in today's issue of the journal Nature Medicine.
› Verified 3 days ago
| Entity Name | Pinnacle Anesthesia Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205103777 PECOS PAC ID: 1850549841 Enrollment ID: O20120917000584 |
News Archive
A Judicial Review sought by the British Medical Association to challenge the government's decision to cap the pensions of GPs will take place in the High Court, London, on Wednesday and Thursday this week (12th and 13th March 2008).
ISENTRESS , an integrase inhibitor from Merck & Co., Inc., was studied in comparison to efavirenz in maintaining viral load suppression to undetectable levels (less than 50 copies/mL) and at improving CD4 cell counts in previously untreated (treatment-naïve) HIV-1-infected patients through 96 weeks in a Phase III study called STARTMRK.
Today's headlines include reports about the health portion of the President's budget blueprint along with the politics that accompany it.
Researchers from the ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) research consortium, have reported that a blood test could soon be an important diagnostic tool in detecting the abnormal proteins deposits in the brain that lead to the progressive and debilitating condition of Alzheimer's disease. The study titled, "Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration," was published in today's issue of the journal Nature Medicine.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Terri L Dallas-prunskis, MD 431 Summit, Elgin, IL 60120 Ph: (847) 289-8822 | Dr Terri L Dallas-prunskis, MD 4309 Medical Center Dr, B103, Mchenry, IL 60050 Ph: (815) 363-9595 |
News Archive
A Judicial Review sought by the British Medical Association to challenge the government's decision to cap the pensions of GPs will take place in the High Court, London, on Wednesday and Thursday this week (12th and 13th March 2008).
ISENTRESS , an integrase inhibitor from Merck & Co., Inc., was studied in comparison to efavirenz in maintaining viral load suppression to undetectable levels (less than 50 copies/mL) and at improving CD4 cell counts in previously untreated (treatment-naïve) HIV-1-infected patients through 96 weeks in a Phase III study called STARTMRK.
Today's headlines include reports about the health portion of the President's budget blueprint along with the politics that accompany it.
Researchers from the ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) research consortium, have reported that a blood test could soon be an important diagnostic tool in detecting the abnormal proteins deposits in the brain that lead to the progressive and debilitating condition of Alzheimer's disease. The study titled, "Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration," was published in today's issue of the journal Nature Medicine.
› Verified 3 days ago